EPISODE · Jan 30, 2024 · 5 MIN
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health.Speaker 3: (00:32)Can you share a little about yourself and your background? Speaker 3: (01:00)Can you provide us with an overview of this new preeclampsia assay? Speaker 3: (02:33)Can you share what will be reported with this assay? Speaker 3: (03:07)Which patients should have this testing and at what point should it be performed? Speaker 3: (03:35)Can you share what alternative test options are available today for preeclampsia? Speaker 3: (03:52)How are the test results used in patient care?
What this episode covers
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' unique blood test identifies pregnant women at risk of developing preeclampsia with severe features. Test results can guide clinical management, to safeguard maternal and neonatal health.Speaker 3: (00:32)Can you share a little about yourself and your background? Speaker 3: (01:00)Can you provide us with an overview of this new preeclampsia assay? Speaker 3: (02:33)Can you share what will be reported with this assay? Speaker 3: (03:07)Which patients should have this testing and at what point should it be performed? Speaker 3: (03:35)Can you share what alternative test options are available today for preeclampsia? Speaker 3: (03:52)How are the test results used in patient care?
NOW PLAYING
Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m